1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment
oleh: Christopher J Nirschl, Nesreen Ismail, Andres Salmeron, Zoe Steuert, Jenna M Sullivan, Heather R Brodkin, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston, Yuka Lewis
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.